Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:51:47 +0200Thu, 16 May 2024 12:30:00 +0200Human medicines European public assessment report (EPAR): Colobreathe, colistimethate sodium, Date of authorisation: 13/02/2012, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/colobreatheHuman medicines European public assessment report (EPAR): Colobreathe, colistimethate sodium, Date of authorisation: 13/02/2012, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/colobreatheThu, 16 May 2024 12:30:00 +0200Human medicineColobreathe : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500123693_en.pdfColobreathe : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500123693_en.pdfWed, 07 Mar 2012 01:00:00 +0100Human medicine